[S02DA03, antipyrine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Antipyrine.]
[A14AA02, stanozolol, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Stanozolol.]
[J01GA01, streptomycin, Nitrofurantoin may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[M03AB01, succinylcholine, The risk or severity of hyperkalemia can be increased when Succinylcholine is combined with Nitrofurantoin.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01CG01, sulbactam, Nitrofurantoin may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, The risk or severity of methemoglobinemia can be increased when Sulfadiazine is combined with Nitrofurantoin.]
[J01EC01, sulfamethoxazole, Nitrofurantoin may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.]
[J01EB04, sulfapyridine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The serum concentration of Nitrofurantoin can be increased when it is combined with Sulfinpyrazone.]
[M01AB02, sulindac, The risk or severity of hyperkalemia can be increased when Sulindac is combined with Nitrofurantoin.]
[M01AX04, apazone, The serum concentration of Nitrofurantoin can be increased when it is combined with Azapropazone.]
[L02BA01, tamoxifen, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Tamoxifen.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[R03CC03, terbutaline, Nitrofurantoin may decrease the excretion rate of Terbutaline which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Nitrofurantoin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Testosterone.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Tetracaine.]
[S03AA02, tetracycline, Nitrofurantoin may decrease the excretion rate of Tetracycline which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Nitrofurantoin may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[G04BE06, moxisylyte, Nitrofurantoin may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Nitrofurantoin may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01ED01, timolol, The risk or severity of hyperkalemia can be increased when Timolol is combined with Nitrofurantoin.]
[P01AB02, tinidazole, Nitrofurantoin may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Nitrofurantoin may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Nitrofurantoin may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[V04CA01, tolbutamide, Nitrofurantoin may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, The risk or severity of hyperkalemia can be increased when Tolmetin is combined with Nitrofurantoin.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Nitrofurantoin may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Nitrofurantoin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A03AA05, trimebutine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Trimebutine.]
[N03AC02, trimethadione, The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Nitrofurantoin.]
[J01EA01, trimethoprim, The risk or severity of hyperkalemia can be increased when Trimethoprim is combined with Nitrofurantoin.]
[C09CA09, azilsartan medoxomil, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Azilsartan medoxomil.]
[R03DX07, roflumilast, Nitrofurantoin may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Nitrofurantoin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[L01EX04, vandetanib, Vandetanib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[R02AA14, oxyquinoline, Nitrofurantoin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[J05AG05, rilpivirine, Rilpivirine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01AA28, vancomycin, Nitrofurantoin may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Nitrofurantoin may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Nitrofurantoin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C08DA01, verapamil, Verapamil may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N06AX09, viloxazine, Nitrofurantoin may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[L01CA01, vinblastine, Vinblastine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01CA02, vincristine, Vincristine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[B01AA03, warfarin, Nitrofurantoin may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE02, indinavir, Indinavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01EC01, vemurafenib, Vemurafenib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M05BA05, tiludronic acid, Nitrofurantoin may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Nitrofurantoin may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01MA13, trovafloxacin, The therapeutic efficacy of Trovafloxacin can be decreased when used in combination with Nitrofurantoin.]
[L01XX02, asparaginase, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Asparaginase Escherichia coli.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Nitrofurantoin may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, Nitrofurantoin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, Nitrofurantoin may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, Nitrofurantoin may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, Atenolol may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01FA01, atropine, Atropine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M01CB03, auranofin, Nitrofurantoin may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[L01XJ01, vismodegib, Vismodegib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[B03XA04, peginesatide, Nitrofurantoin may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Nitrofurantoin may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, Nitrofurantoin may decrease the excretion rate of Azathioprine which could result in a higher serum level.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[G04BE10, avanafil, Avanafil may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A08AA11, lorcaserin, Nitrofurantoin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Nitrofurantoin may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[V03AX03, cobicistat, Cobicistat may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L02BB04, enzalutamide, Nitrofurantoin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[L04AA31, teriflunomide, Teriflunomide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01EX05, regorafenib, Regorafenib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[D02BA02, octinoxate, Nitrofurantoin may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, Nelfinavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N04BD02, rasagiline, Nitrofurantoin may decrease the excretion rate of Rasagiline which could result in a higher serum level.]
[C08CA13, lercanidipine, The risk or severity of hyperkalemia can be increased when Lercanidipine is combined with Nitrofurantoin.]
[V09IX04, fluorodeoxyglucose F18, Nitrofurantoin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[V08CA11, gadofosveset, Nitrofurantoin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, Ponatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A16AX08, teduglutide, Nitrofurantoin may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[C04AX11, bencyclane, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Bencyclane.]
[A10BH04, alogliptin, Nitrofurantoin may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Nitrofurantoin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, Nitrofurantoin may decrease the excretion rate of Pomalidomide which could result in a higher serum level.]
[N02BA10, benorilate, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Benorilate.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01MA15, gemifloxacin, The therapeutic efficacy of Gemifloxacin can be decreased when used in combination with Nitrofurantoin.]
[M04AB03, benzbromarone, The serum concentration of Nitrofurantoin can be increased when it is combined with Benzbromarone.]
[S01AE07, moxifloxacin, The therapeutic efficacy of Moxifloxacin can be decreased when used in combination with Nitrofurantoin.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Benzocaine.]
[L03AA12, ancestim, Nitrofurantoin may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, Celecoxib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01EC02, dabrafenib, Dabrafenib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[R02AX03, benzydamine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Benzydamine.]
[L01EE01, trametinib, Nitrofurantoin may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Benzyl alcohol.]
[V09AX05, florbetapir F-18, Nitrofurantoin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[L01EB03, afatinib, Afatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N06AX28, levomilnacipran, Nitrofurantoin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[C08EA02, bepridil, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Bepridil.]
[A10BJ03, lixisenatide, Nitrofurantoin may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[A05AA03, cholic acid, Cholic Acid may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C02KX04, macitentan, Nitrofurantoin may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[N06AX26, vortioxetine, Nitrofurantoin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AP05, simeprevir, Simeprevir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AP08, sofosbuvir, Nitrofurantoin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Nitrofurantoin may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[C07AB04, acebutolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Acebutolol.]
[N05CH03, tasimelteon, Nitrofurantoin may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[L04AA32, apremilast, Nitrofurantoin may decrease the excretion rate of Apremilast which could result in a higher serum level.]
[L02BG02, formestane, Nitrofurantoin may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S01ED02, betaxolol, The risk or severity of hyperkalemia can be increased when Betaxolol is combined with Nitrofurantoin.]
[V03AB34, fomepizole, Nitrofurantoin may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Nitrofurantoin is combined with Acenocoumarol.]
[N07XX08, tafamidis, The serum concentration of Nitrofurantoin can be increased when it is combined with Tafamidis.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S03AA06, gentamicin, Nitrofurantoin may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[J05AP09, dasabuvir, Dasabuvir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Nitrofurantoin is combined with Dicoumarol.]
[B01AF03, edoxaban, Nitrofurantoin may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[L01EF01, palbociclib, Palbociclib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01EX08, lenvatinib, Lenvatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AP07, daclatasvir, Daclatasvir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N02BE01, acetaminophen, The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Nitrofurantoin.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Nitrofurantoin is combined with Tioclomarol.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A04AD14, rolapitant, Rolapitant may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M02AA25, aceclofenac, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Acemetacin.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC03, lansoprazole, Lansoprazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[V03AB37, idarucizumab, Nitrofurantoin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[J02AC05, isavuconazole, Isavuconazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01EB04, osimertinib, Osimertinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Nitrofurantoin.]
[L01XG03, ixazomib, Nitrofurantoin may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[L01ED03, alectinib, Alectinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M04AB05, lesinurad, The serum concentration of Nitrofurantoin can be increased when it is combined with Lesinurad.]
[J05AP10, elbasvir, Elbasvir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AP11, grazoprevir, Grazoprevir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M01AE16, alminoprofen, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Alminoprofen.]
[N03AX23, brivaracetam, Nitrofurantoin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[L01XX52, venetoclax, Venetoclax may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05BA08, bromazepam, Nitrofurantoin may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, Nitrofurantoin may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[C08CA01, amlodipine, The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Nitrofurantoin.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Bupivacaine.]
[C07AA19, bupranolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Bupranolol.]
[N07BC01, buprenorphine, Buprenorphine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01XX27, arsenic trioxide, Nitrofurantoin may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01MA09, sparfloxacin, The therapeutic efficacy of Sparfloxacin can be decreased when used in combination with Nitrofurantoin.]
[L01XK03, rucaparib, Rucaparib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A07EC04, balsalazide, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Balsalazide.]
[A06AH05, naldemedine, Nitrofurantoin may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Nitrofurantoin may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N06BC01, caffeine, Caffeine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C09AA07, benazepril, The risk or severity of hyperkalemia can be increased when Benazepril is combined with Nitrofurantoin.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Oxybuprocaine.]
[P01CA02, benznidazole, Nitrofurantoin may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J05AF06, abacavir, Nitrofurantoin may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[J05AE09, tipranavir, Tipranavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N07XX13, valbenazine, Nitrofurantoin may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L01ED04, brigatinib, Brigatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N04BD03, safinamide, Safinamide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01MA23, delafloxacin, The therapeutic efficacy of Delafloxacin can be decreased when used in combination with Nitrofurantoin.]
[L01BC06, capecitabine, Nitrofurantoin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XX59, enasidenib, Enasidenib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01EF03, abemaciclib, Abemaciclib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C07AB07, bisoprolol, The risk or severity of hyperkalemia can be increased when Bisoprolol is combined with Nitrofurantoin.]
[J05AG03, efavirenz, Efavirenz may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C07AA17, bopindolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Bopindolol.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Nitrofurantoin may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[M01AB07, bumadizone, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Bumadizone.]
[J05AX18, letermovir, Letermovir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Capsaicin.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Nitrofurantoin may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Captopril.]
[L02BB05, apalutamide, Apalutamide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AF01, carbamazepine, Nitrofurantoin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C07AG02, carvedilol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Carvedilol.]
[B02BX09, fostamatinib, Fostamatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N03AX24, cannabidiol, Cannabidiol may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[B02BX08, avatrombopag, Avatrombopag may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L04AA37, baricitinib, Nitrofurantoin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01GB14, plazomicin, Nitrofurantoin may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Celiprolol.]
[A16AX14, migalastat, Nitrofurantoin may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The excretion of Nitrofurantoin can be decreased when combined with Stiripentol.]
[L01EB07, dacomitinib, Dacomitinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Chloroprocaine.]
[D08AE05, chloroxylenol, Nitrofurantoin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Lornoxicam.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01EX13, gilteritinib, Gilteritinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01XJ03, glasdegib, Glasdegib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A06AX05, prucalopride, Nitrofurantoin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C09AA08, cilazapril, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Cilazapril.]
[B01AC23, cilostazol, Nitrofurantoin may decrease the excretion rate of Cilostazol which could result in a higher serum level.]
[J01FA09, clarithromycin, Nitrofurantoin may decrease the excretion rate of Clarithromycin which could result in a higher serum level.]
[N06BA14, solriamfetol, Nitrofurantoin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[N05BA09, clobazam, Clobazam may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C09CA06, candesartan, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Candesartan.]
[J01DC04, cefaclor, Nitrofurantoin may decrease the excretion rate of Cefaclor which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L02BB06, darolutamide, The serum concentration of Nitrofurantoin can be increased when it is combined with Darolutamide.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01EJ02, fedratinib, Fedratinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N07XX11, pitolisant, Nitrofurantoin may decrease the excretion rate of Pitolisant which could result in a higher serum level.]
[N04CX01, istradefylline, Istradefylline may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N02CC08, lasmiditan, The serum concentration of Nitrofurantoin can be increased when it is combined with Lasmiditan.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M09AX08, golodirsen, Nitrofurantoin may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Nitrofurantoin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[S01AE06, gatifloxacin, The therapeutic efficacy of Gatifloxacin can be decreased when used in combination with Nitrofurantoin.]
[R02AA03, dichlorobenzyl alcohol, Nitrofurantoin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Nitrofurantoin may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[M01AH02, rofecoxib, The risk or severity of hyperkalemia can be increased when Rofecoxib is combined with Nitrofurantoin.]
[C08CA16, clevidipine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Clevidipine.]
[N02BA03, choline salicylate, Nitrofurantoin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[V09AB03, ioflupane I-123, Nitrofurantoin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Nitrofurantoin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Nitrofurantoin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[V04CH02, indigo carmine, Nitrofurantoin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[N05CC01, chloral hydrate, Nitrofurantoin may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[N03AG01, valproic acid, The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Nitrofurantoin.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A05AA02, ursodiol, Ursodeoxycholic acid may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01AA13, fusidic acid, Fusidic acid may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01MB04, pipemidic acid, The therapeutic efficacy of Pipemidic acid can be decreased when used in combination with Nitrofurantoin.]
[L01EX17, capmatinib, The serum concentration of Nitrofurantoin can be increased when it is combined with Capmatinib.]
[M01AC04, droxicam, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Droxicam.]
[L01EX19, ripretinib, Ripretinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[V08CA05, mangafodipir, Nitrofurantoin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[M02AA27, dexketoprofen, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Dexketoprofen.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Dyclonine.]
[J05AX29, fostemsavir, Fostemsavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01FX15, belantamab mafodotin, Nitrofurantoin may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.]
[P01BA01, chloroquine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Nitrofurantoin.]
[L01EX23, pralsetinib, Pralsetinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AA01, chlorpromazine, Chlorpromazine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N02BA07, ethenzamide, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Ethenzamide.]
[N06BX18, vinpocetine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Vinpocetine.]
[M01AB08, etodolac, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Etofenamate.]
[M01AX25, chondroitin sulfates, Nitrofurantoin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[L01EX21, tepotinib, Tepotinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M01AE05, fenbufen, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Fenbufen.]
[C01CA19, fenoldopam, Nitrofurantoin may decrease the excretion rate of Fenoldopam which could result in a higher serum level.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01MB07, flumequine, The therapeutic efficacy of Flumequine can be decreased when used in combination with Nitrofurantoin.]
[S02BA08, fluocinolone acetonide, Fluocinolone acetonide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01JA01, fluorescein, Fluorescein may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N02BG07, flupirtine, Nitrofurantoin may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[L01EK03, tivozanib, Tivozanib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A02BA01, cimetidine, Cimetidine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N07CA02, cinnarizine, The risk or severity of hyperkalemia can be increased when Cinnarizine is combined with Nitrofurantoin.]
[J01MB06, cinoxacin, The therapeutic efficacy of Cinoxacin can be decreased when used in combination with Nitrofurantoin.]
[L01XX73, sotorasib, The serum concentration of Nitrofurantoin can be increased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The therapeutic efficacy of Ciprofloxacin can be decreased when used in combination with Nitrofurantoin.]
[L01XA01, cisplatin, Nitrofurantoin may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA48, belumosudil, Belumosudil may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M01AG01, mefenamic acid, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Mefenamic acid.]
[A10BB12, glimepiride, Glimepiride may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AX10, maribavir, Maribavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J04BA01, clofazimine, Clofazimine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C10AB01, clofibrate, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Clofibrate.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Nitrofurantoin can be increased when it is combined with Pacritinib.]
[N06AA04, clomipramine, Nitrofurantoin may decrease the excretion rate of Clomipramine which could result in a higher serum level.]
[N03AE01, clonazepam, Nitrofurantoin may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J02AC06, oteseconazole, The serum concentration of Nitrofurantoin can be increased when it is combined with Oteseconazole.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[A05BA08, glycyrrhizic acid, Nitrofurantoin may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.]
[N05AH02, clozapine, Clozapine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A10BK06, sotagliflozin, Sotagliflozin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01GB12, arbekacin, Nitrofurantoin may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Cocaine.]
[M01AX13, proquazone, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Proquazone.]
[M04AC01, colchicine, Nitrofurantoin may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Nitrofurantoin may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A04AA03, tropisetron, Nitrofurantoin may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, Nitrofurantoin may decrease the excretion rate of Nateglinide which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Imidazole salicylate.]
[R03BA08, ciclesonide, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Ciclesonide.]
[B01AC10, indobufen, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Indobufen.]
[J05AB14, valganciclovir, Nitrofurantoin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Nitrofurantoin may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Nitrofurantoin may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Nitrofurantoin may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Nitrofurantoin may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Nitrofurantoin may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The risk or severity of hyperkalemia can be increased when Valdecoxib is combined with Nitrofurantoin.]
[A03AX10, isometheptene, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Isometheptene.]
[N02CC05, almotriptan, Nitrofurantoin may decrease the excretion rate of Almotriptan which could result in a higher serum level.]
[M01AH04, parecoxib, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Parecoxib.]
[J02AC02, itraconazole, Itraconazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[B01AB12, bemiparin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Bemiparin.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05BA10, ketazolam, Nitrofurantoin may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Kebuzone.]
[L01EA01, imatinib, Imatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C08CA09, lacidipine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Lacidipine.]
[V03AF07, rasburicase, The risk or severity of methemoglobinemia can be increased when Rasburicase is combined with Nitrofurantoin.]
[N03AX09, lamotrigine, The risk or severity of hyperkalemia can be increased when Lamotrigine is combined with Nitrofurantoin.]
[N07BC04, lofexidine, Nitrofurantoin may decrease the excretion rate of Lofexidine which could result in a higher serum level.]
[S01AE04, lomefloxacin, The therapeutic efficacy of Lomefloxacin can be decreased when used in combination with Nitrofurantoin.]
[M01AB09, lonazolac, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Lonazolac.]
[R06AX13, loratadine, Loratadine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M02AA31, loxoprofen, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Loxoprofen.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C09AA03, lisinopril, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Lisinopril.]
[A06AD01, magnesium carbonate, Nitrofurantoin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Manidipine.]
[C07AA14, mepindolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Mepindolol.]
[H02AB15, meprednisone, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Meprednisone.]
[J01DH02, meropenem, Nitrofurantoin may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[C04AX01, cyclandelate, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Cyclandelate.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Nitrofurantoin may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01AA01, cyclophosphamide, The risk or severity of methemoglobinemia can be increased when Cyclophosphamide is combined with Nitrofurantoin.]
[S01XA18, cyclosporine, Cyclosporine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C09AA13, moexipril, The risk or severity of hyperkalemia can be increased when Moexipril is combined with Nitrofurantoin.]
[C10AA07, rosuvastatin, Nitrofurantoin may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[M02AA02, mofebutazone, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Morniflumate.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AH05, etoricoxib, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Etoricoxib.]
[L01AX04, dacarbazine, Nitrofurantoin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[G03XA01, danazol, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Danazol.]
[M03CA01, dantrolene, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Dantrolene.]
[J04BA02, dapsone, The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Nitrofurantoin.]
[L01DB02, daunorubicin, Daunorubicin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M01AX01, nabumetone, The risk or severity of hyperkalemia can be increased when Nabumetone is combined with Nitrofurantoin.]
[N07BB05, nalmefene, Nitrofurantoin may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[B05XA15, potassium lactate, Potassium lactate may increase the hyperkalemic activities of Nitrofurantoin.]
[C07AB12, nebivolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Nebivolol.]
[S01GX04, nedocromil, Nitrofurantoin may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, Nitrofurantoin may decrease the excretion rate of Nefazodone which could result in a higher serum level.]
[C01DX16, nicorandil, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Nicorandil.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M03AC11, cisatracurium, Nitrofurantoin may increase the neuromuscular blocking activities of Cisatracurium.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A07EC03, olsalazine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Olsalazine.]
[N06AA01, desipramine, Nitrofurantoin may decrease the excretion rate of Desipramine which could result in a higher serum level.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C09XA02, aliskiren, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Aliskiren.]
[M01AE12, oxaprozin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Oxaprozin.]
[S03BA01, dexamethasone, Dexamethasone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01EB01, gefitinib, Gefitinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N07BC06, heroin, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Diamorphine.]
[C01DA05, pentaerythritol tetranitrate, Nitrofurantoin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[P03AC04, permethrin, Nitrofurantoin may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Nitrofurantoin may decrease the excretion rate of Diazepam which could result in a higher serum level.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Cinchocaine.]
[R05DA08, pholcodine, Nitrofurantoin may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Diclofenac may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A03AA07, dicyclomine, Nitrofurantoin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF02, didanosine, Nitrofurantoin may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[A03AX04, pinaverium, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Pinaverium.]
[L01EB02, erlotinib, Erlotinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[L02AA01, diethylstilbestrol, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Diethylstilbestrol.]
[C08CA03, isradipine, Isradipine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[D07XC04, diflucortolone, Nitrofurantoin may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Diflunisal.]
[C01AA05, digoxin, Nitrofurantoin may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C10AX09, ezetimibe, Nitrofurantoin may decrease the excretion rate of Ezetimibe which could result in a higher serum level.]
[L01XX24, pegaspargase, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Pegaspargase.]
[C04AE04, dihydroergocristine, Nitrofurantoin may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AE08, atazanavir, Nitrofurantoin may decrease the excretion rate of Atazanavir which could result in a higher serum level.]
[H03BC01, potassium perchlorate, Potassium perchlorate may increase the hyperkalemic activities of Nitrofurantoin.]
[V03AB04, pralidoxime, Nitrofurantoin may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Pramocaine.]
[C08DB01, diltiazem, The risk or severity of hyperkalemia can be increased when Diltiazem is combined with Nitrofurantoin.]
[V03AB09, dimercaprol, Nitrofurantoin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, Nitrofurantoin may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N02BB04, propyphenazone, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Proglumetacin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Diphenhydramine.]
[C09AA06, quinapril, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Quinapril.]
[B01AC07, dipyridamole, Nitrofurantoin may decrease the excretion rate of Dipyridamole which could result in a higher serum level.]
[C09AA05, ramipril, The risk or severity of hyperkalemia can be increased when Ramipril is combined with Nitrofurantoin.]
[S01AX06, resorcinol, Nitrofurantoin may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Disopyramide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[P03AA04, disulfiram, Nitrofurantoin may decrease the excretion rate of Disulfiram which could result in a higher serum level.]
[R06AE09, levocetirizine, Nitrofurantoin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Ropivacaine.]
[J01MB01, rosoxacin, The therapeutic efficacy of Rosoxacin can be decreased when used in combination with Nitrofurantoin.]
[L01EX01, sunitinib, Sunitinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE08, tadalafil, Nitrofurantoin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01BC05, ketorolac, The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Nitrofurantoin.]
[C01EB18, ranolazine, Ranolazine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N02BA06, salsalate, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Salsalate.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C01CA07, dobutamine, Nitrofurantoin may decrease the excretion rate of Dobutamine which could result in a higher serum level.]
[C01CA04, dopamine, Nitrofurantoin may decrease the excretion rate of Dopamine which could result in a higher serum level.]
[N06AA12, doxepin, Nitrofurantoin may decrease the excretion rate of Doxepin which could result in a higher serum level.]
[L01DB01, doxorubicin, Nitrofurantoin may decrease the excretion rate of Doxorubicin which could result in a higher serum level.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A08AA10, sibutramine, Nitrofurantoin may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[C10AA01, simvastatin, Simvastatin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[V03AG05, sodium phosphate, Sodium phosphate, monobasic may increase the hyperkalemic activities of Nitrofurantoin.]
[A12CA02, sodium sulfate, Nitrofurantoin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[C09AA11, spirapril, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Spirapril.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[V04CX07, edrophonium, Nitrofurantoin may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[C07AB13, talinolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Talinolol.]
[J01MA05, temafloxacin, The therapeutic efficacy of Temafloxacin can be decreased when used in combination with Nitrofurantoin.]
[L01AX03, temozolomide, Nitrofurantoin may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, The risk or severity of hyperkalemia can be increased when Tenoxicam is combined with Nitrofurantoin.]
[G04BD05, terodiline, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Terodiline.]
[C07AA16, tertatolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Tertatolol.]
[C09AA02, enalapril, The risk or severity of hyperkalemia can be increased when Enalapril is combined with Nitrofurantoin.]
[M01AG02, tolfenamic acid, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Tolfenamic acid.]
[N06AG03, toloxatone, Nitrofurantoin may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA10, trandolapril, The risk or severity of hyperkalemia can be increased when Trandolapril is combined with Nitrofurantoin.]
[J01MA04, enoxacin, The therapeutic efficacy of Enoxacin can be decreased when used in combination with Nitrofurantoin.]
[N06AX16, venlafaxine, Venlafaxine may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA12, mepirodipine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Barnidipine.]
[C09AA15, zofenopril, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Zofenopril.]
[M01AB04, zomepirac, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Zomepirac.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF01, zopiclone, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Zopiclone.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C02AC02, guanfacine, Nitrofurantoin may decrease the excretion rate of Guanfacine which could result in a higher serum level.]
[L03AX05, pidotimod, Nitrofurantoin may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, Erythromycin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CD04, estazolam, Nitrofurantoin may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[G03CA03, estradiol, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Estradiol.]
[G03CC06, estriol, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Estriol.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Conjugated estrogens.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[R03BA09, fluticasone furoate, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Fluticasone furoate.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L02AA03, ethinyl estradiol, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Ethinylestradiol.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N03AD01, ethosuximide, The risk or severity of hyperkalemia can be increased when Ethosuximide is combined with Nitrofurantoin.]
[N03AB01, ethotoin, The therapeutic efficacy of Ethotoin can be increased when used in combination with Nitrofurantoin.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Etidocaine.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L04AD02, tacrolimus, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Tacrolimus.]
[J01MA08, fleroxacin, The therapeutic efficacy of Fleroxacin can be decreased when used in combination with Nitrofurantoin.]
[R06AX11, astemizole, Astemizole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[R06AX12, terfenadine, Terfenadine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[P01AX07, trimetrexate, Nitrofurantoin may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Nitrofurantoin may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[N06AB08, fluvoxamine, Fluvoxamine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C10AA03, pravastatin, Pravastatin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Nitrofurantoin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[D11AX24, deoxycholic acid, Deoxycholic acid may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[B05AA05, dextran, Nitrofurantoin may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C08CA02, felodipine, Nitrofurantoin may decrease the excretion rate of Felodipine which could result in a higher serum level.]
[C08EA01, fendiline, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Fendiline.]
[M01AE04, fenoprofen, The risk or severity of hyperkalemia can be increased when Fenoprofen is combined with Nitrofurantoin.]
[N02AB03, fentanyl, Nitrofurantoin may decrease the excretion rate of Fentanyl which could result in a higher serum level.]
[R03CC02, albuterol, Nitrofurantoin may decrease the excretion rate of Salbutamol which could result in a higher serum level.]
[L01BB06, clofarabine, Clofarabine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[G04BD02, flavoxate, Nitrofurantoin may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[N02BG04, floctafenine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Floctafenine.]
[J01CF05, floxacillin, Flucloxacillin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J02AC01, fluconazole, The risk or severity of adverse effects can be increased when Nitrofurantoin is combined with Fluconazole.]
[J02AX01, flucytosine, Nitrofurantoin may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Nitrofurantoin may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[N07CA03, flunarizine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Flunarizine.]
[D07AC08, fluocinonide, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Fluocinonide.]
[L01BC09, floxuridine, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Floxuridine.]
[L01BC02, fluorouracil, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Fluorouracil.]
[N05CD01, flurazepam, Flurazepam may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01BC04, flurbiprofen, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Flurbiprofen.]
[N05AG01, fluspirilene, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Fluspirilene.]
[L02BB01, flutamide, The risk or severity of methemoglobinemia can be increased when Flutamide is combined with Nitrofurantoin.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S02AA17, fosfomycin, Nitrofurantoin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01BC03, tegafur, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Tegafur.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C08DA02, gallopamil, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Gallopamil.]
[S01AD09, ganciclovir, Nitrofurantoin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C10AB04, gemfibrozil, Nitrofurantoin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.]
[J01XA03, telavancin, Nitrofurantoin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, Dasatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N03AD03, methsuximide, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Methsuximide.]
[A10BB01, glyburide, Glyburide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A10BB07, glipizide, Nitrofurantoin may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C05AE01, nitroglycerin, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Nitroglycerin.]
[L01EX02, sorafenib, Sorafenib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C07AB09, esmolol, The risk or severity of hyperkalemia can be increased when Esmolol is combined with Nitrofurantoin.]
[M01CB04, aurothioglucose, Nitrofurantoin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Nitrofurantoin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Nitrofurantoin is combined with Fluindione.]
[C09AA09, fosinopril, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Nitrofurantoin.]
[S01EX01, guanethidine, Nitrofurantoin may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05AD01, haloperidol, Haloperidol may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05AH04, quetiapine, Nitrofurantoin may decrease the excretion rate of Quetiapine which could result in a higher serum level.]
[N06BX13, idebenone, Nitrofurantoin may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[M04AA01, allopurinol, The serum concentration of Nitrofurantoin can be increased when it is combined with Allopurinol.]
[C09CA01, losartan, Losartan may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01XA14, heparin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Heparin.]
[G03DC01, allylestrenol, Nitrofurantoin may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Nitrofurantoin.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C08CA10, nilvadipine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Nimesulide.]
[C09AA04, perindopril, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Perindopril.]
[C02DB02, hydralazine, Nitrofurantoin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Potassium acetate may increase the hyperkalemic activities of Nitrofurantoin.]
[S01XA07, aluminum potassium sulfate, Potassium alum may increase the hyperkalemic activities of Nitrofurantoin.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[G04BD06, propiverine, Nitrofurantoin may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[B05AA07, hetastarch, Nitrofurantoin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[L01XX05, hydroxyurea, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Hydroxyurea.]
[R02AX02, ibuprofen, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Ibuprofen.]
[B05XA08, sodium acetate, Nitrofurantoin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01AA06, ifosfamide, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Ifosfamide.]
[N06AA02, imipramine, Imipramine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01CD01, paclitaxel, Paclitaxel may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[R01AD07, tixocortol, Nitrofurantoin may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[L01CE01, topotecan, Nitrofurantoin may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, Indomethacin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A11HA07, inositol, Nitrofurantoin may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, Nitrofurantoin may decrease the excretion rate of Milnacipran which could result in a higher serum level.]
[S01XA28, varenicline, Nitrofurantoin may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Articaine.]
[A10BH01, sitagliptin, Nitrofurantoin may decrease the excretion rate of Sitagliptin which could result in a higher serum level.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CH02, ramelteon, Nitrofurantoin may decrease the excretion rate of Ramelteon which could result in a higher serum level.]
[C10AA06, cerivastatin, Cerivastatin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C07AA01, alprenolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Alprenolol.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, Nitrofurantoin may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[C09AA16, imidapril, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Imidapril.]
[J04AC01, isoniazid, Nitrofurantoin may decrease the excretion rate of Isoniazid which could result in a higher serum level.]
[J05AX05, inosine pranobex, Nitrofurantoin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Isosorbide mononitrate.]
[C05AE02, isosorbide dinitrate, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Isosorbide dinitrate.]
[D10BA01, isotretinoin, Nitrofurantoin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[S01AA24, kanamycin, Nitrofurantoin may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[N01AX03, ketamine, Nitrofurantoin may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[B01AC22, prasugrel, Nitrofurantoin may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[J02AB02, ketoconazole, Ketoconazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M02AA10, ketoprofen, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Ketoprofen.]
[J01MB02, nalidixic acid, The therapeutic efficacy of Nalidixic acid can be decreased when used in combination with Nitrofurantoin.]
[M01AE11, tiaprofenic acid, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Tiaprofenic acid.]
[C07AG01, labetalol, The risk or severity of hyperkalemia can be increased when Labetalol is combined with Nitrofurantoin.]
[N04BB01, amantadine, Nitrofurantoin may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Nitrofurantoin.]
[A06AX03, lubiprostone, Nitrofurantoin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Lidocaine.]
[C08EX01, lidoflazine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Lidoflazine.]
[S01AA21, amikacin, Nitrofurantoin may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[A07DA03, loperamide, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Loperamide.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C10AA02, lovastatin, Lovastatin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[B05XA11, magnesium chloride, Nitrofurantoin may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Nitrofurantoin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[V04CC02, magnesium sulfate, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Nitrofurantoin.]
[L01BA05, pralatrexate, Nitrofurantoin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, Nilotinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Nitrofurantoin may decrease the excretion rate of Maprotiline which could result in a higher serum level.]
[C02BB01, mecamylamine, Mecamylamine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M02AA18, meclofenamic acid, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Meclofenamic acid.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB06, nadroparin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Nadroparin.]
[B01AB05, enoxaparin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Enoxaparin.]
[B01AB04, dalteparin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Dalteparin.]
[N06DX01, memantine, Nitrofurantoin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N03AB04, mephenytoin, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Mephenytoin.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Mepivacaine.]
[G04BX16, tiopronin, Nitrofurantoin may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Nitrofurantoin may decrease the excretion rate of Paliperidone which could result in a higher serum level.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N07BC02, methadone, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Methadone.]
[N06BA03, methamphetamine, Nitrofurantoin may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[J05AF05, lamivudine, Nitrofurantoin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, Nitrofurantoin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01BA04, pemetrexed, Nitrofurantoin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L04AX03, methotrexate, Methotrexate may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, Nitrofurantoin may decrease the excretion rate of Methyldopa which could result in a higher serum level.]
[V04CG05, methylene blue, Nitrofurantoin may decrease the excretion rate of Methylene blue which could result in a higher serum level.]
[G03EK01, methyltestosterone, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Methyltestosterone.]
[A03FA01, metoclopramide, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Metoclopramide.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, The risk or severity of hyperkalemia can be increased when Metoprolol is combined with Nitrofurantoin.]
[V04CD01, metyrapone, Nitrofurantoin may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[N02BB03, aminopyrine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Aminophenazone.]
[B01AB07, parnaparin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Parnaparin.]
[N05CD08, midazolam, Midazolam may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[G03XB01, mifepristone, Nitrofurantoin may decrease the excretion rate of Mifepristone which could result in a higher serum level.]
[B01AB10, tinzaparin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Tinzaparin.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C09CA03, valsartan, The risk or severity of hyperkalemia can be increased when Valsartan is combined with Nitrofurantoin.]
[L01XX23, mitotane, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Mitotane.]
[L03AC01, aldesleukin, Aldesleukin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C01BD01, amiodarone, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Amiodarone.]
[N06AA09, amitriptyline, Amitriptyline may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L04AB05, certolizumab pegol, Nitrofurantoin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[B02BX05, eltrombopag, Eltrombopag may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[G04BA01, ammonium chloride, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Ammonium chloride.]
[L04AA06, mycophenolic acid, Nitrofurantoin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[N03AB05, fosphenytoin, The therapeutic efficacy of Fosphenytoin can be increased when used in combination with Nitrofurantoin.]
[C07AA12, nadolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Nadolol.]
[J01CA04, amoxicillin, Nitrofurantoin may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[V03AB15, naloxone, Nitrofurantoin may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[S01XA11, nandrolone, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Nandrolone phenpropionate.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M02AA12, naproxen, Nitrofurantoin may decrease the excretion rate of Naproxen which could result in a higher serum level.]
[A10BG01, troglitazone, Troglitazone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N06AX21, duloxetine, Duloxetine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S03AA01, neomycin, Nitrofurantoin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A10BX02, repaglinide, Nitrofurantoin may decrease the excretion rate of Repaglinide which could result in a higher serum level.]
[B01AC17, tirofiban, Nitrofurantoin may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L03AX16, plerixafor, Nitrofurantoin may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Nitrofurantoin may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Nitrofurantoin may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M04AA03, febuxostat, The excretion of Nitrofurantoin can be decreased when combined with Febuxostat.]
[C01CE01, inamrinone, Nitrofurantoin may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[C10AD02, niacin, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Niacin.]
[C08CA04, nicardipine, Nicardipine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C08CA05, nifedipine, Nitrofurantoin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M02AA17, niflumic acid, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Niflumic acid.]
[V03AB22, amyl nitrite, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Amyl Nitrite.]
[C08CA06, nimodipine, The risk or severity of hyperkalemia can be increased when Nimodipine is combined with Nitrofurantoin.]
[C08CA07, nisoldipine, The risk or severity of hyperkalemia can be increased when Nisoldipine is combined with Nitrofurantoin.]
[C08CA08, nitrendipine, Nitrofurantoin may decrease the excretion rate of Nitrendipine which could result in a higher serum level.]
[R07AX01, nitric oxide, The risk or severity of methemoglobinemia can be increased when Nitric Oxide is combined with Nitrofurantoin.]
[N05CF03, zaleplon, Nitrofurantoin may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C02DD01, nitroprusside, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Nitrofurantoin.]
[N01AX13, nitrous oxide, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Nitrous oxide.]
[S01AE02, norfloxacin, The therapeutic efficacy of Norfloxacin can be decreased when used in combination with Nitrofurantoin.]
[C02KX01, bosentan, Bosentan may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[G02CA02, nylidrin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Nylidrin.]
[B01AB08, reviparin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Reviparin.]
[S02AA16, ofloxacin, The therapeutic efficacy of Ofloxacin can be decreased when used in combination with Nitrofurantoin.]
[A02BC01, omeprazole, Omeprazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N02AA02, opium, Nitrofurantoin may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04CA02, tamsulosin, Nitrofurantoin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01CF04, oxacillin, Nitrofurantoin may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[A14AA08, oxandrolone, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Oxandrolone.]
[N05BA04, oxazepam, Nitrofurantoin may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[J01MB05, oxolinic acid, The therapeutic efficacy of Oxolinic acid can be decreased when used in combination with Nitrofurantoin.]
[C07AA02, oxprenolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Oxprenolol.]
[A14AA05, oxymetholone, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Oxymetholone.]
[S01BC02, oxyphenbutazone, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Oxyphenbutazone.]
[J04AA01, aminosalicylic acid, The risk or severity of methemoglobinemia can be increased when Aminosalicylic acid is combined with Nitrofurantoin.]
[B01AB09, danaparoid, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Danaparoid.]
[J04AB30, capreomycin, Nitrofurantoin may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01MA03, pefloxacin, The therapeutic efficacy of Pefloxacin can be decreased when used in combination with Nitrofurantoin.]
[G04BD11, fesoterodine, Nitrofurantoin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Penbutolol.]
[N05AG03, penfluridol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Penfluridol.]
[J01CE09, penicillin G procaine, Nitrofurantoin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, Pentobarbital may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01XX08, pentostatin, Nitrofurantoin may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Nitrofurantoin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C08EX02, perhexiline, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Perhexiline.]
[G04BX06, phenazopyridine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Phenazopyridine.]
[N06AF03, phenelzine, Nitrofurantoin may decrease the excretion rate of Phenelzine which could result in a higher serum level.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Nitrofurantoin is combined with Phenindione.]
[N03AA02, phenobarbital, Phenobarbital may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Nitrofurantoin is combined with Phenprocoumon.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M02AA01, phenylbutazone, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Phenylbutazone.]
[N03AB02, phenytoin, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Nitrofurantoin.]
[S01AE05, levofloxacin, The therapeutic efficacy of Levofloxacin can be decreased when used in combination with Nitrofurantoin.]
[B02BA01, vitamin K1, Nitrofurantoin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C08CX01, mibefradil, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Mibefradil.]
[C07AA03, pindolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Pindolol.]
[C10AA05, atorvastatin, Nitrofurantoin may decrease the excretion rate of Atorvastatin which could result in a higher serum level.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AE01, saquinavir, Saquinavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N06BX03, piracetam, Nitrofurantoin may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Eprosartan.]
[S01BC06, piroxicam, The risk or severity of hyperkalemia can be increased when Piroxicam is combined with Nitrofurantoin.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01MA11, grepafloxacin, The therapeutic efficacy of Grepafloxacin can be decreased when used in combination with Nitrofurantoin.]
[C09CA04, irbesartan, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Irbesartan.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, Ritonavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A10BH03, saxagliptin, Nitrofurantoin may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Potassium chloride may increase the hyperkalemic activities of Nitrofurantoin.]
[V03AB21, potassium iodide, Potassium Iodide may increase the hyperkalemic activities of Nitrofurantoin.]
[C10AA08, pitavastatin, Nitrofurantoin may decrease the excretion rate of Pitavastatin which could result in a higher serum level.]
[C07AB01, practolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Practolol.]
[H02AB07, prednisone, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Prednisone.]
[C01DX02, prenylamine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Prenylamine.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Prilocaine.]
[P01BA03, primaquine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Primaquine.]
[M04AB01, probenecid, The serum concentration of Nitrofurantoin can be increased when it is combined with Probenecid.]
[C01BA02, procainamide, Nitrofurantoin may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Procaine.]
[C10AB05, fenofibrate, Nitrofurantoin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[G03DA04, progesterone, Progesterone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[R06AD02, promethazine, Nitrofurantoin may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[C01BC03, propafenone, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Propafenone.]
[A03AB05, propantheline, Nitrofurantoin may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[C07AA05, propranolol, The risk or severity of hyperkalemia can be increased when Propranolol is combined with Nitrofurantoin.]
[N02CC04, rizatriptan, Nitrofurantoin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[B01AC09, epoprostenol, Nitrofurantoin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.]
[N07XX07, dalfampridine, Nitrofurantoin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Nitrofurantoin may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A12BA05, potassium gluconate, Potassium gluconate may increase the hyperkalemic activities of Nitrofurantoin.]
[C01BA01, quinidine, Nitrofurantoin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, The risk or severity of methemoglobinemia can be increased when Quinine is combined with Nitrofurantoin.]
[A02BA02, ranitidine, Nitrofurantoin may decrease the excretion rate of Ranitidine which could result in a higher serum level.]
[C02AA01, rescinnamine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Rescinnamine.]
[C02AA02, reserpine, Reserpine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AP01, ribavirin, Nitrofurantoin may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[J04AB02, rifampin, Rifampicin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N02BA05, salicylamide, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Salicylamide.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01BC08, salicylic acid, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Salicylic acid.]
[N05CA06, secobarbital, Secobarbital may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01GB08, sisomicin, Nitrofurantoin may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Nitrofurantoin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Nitrofurantoin may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C07AA07, sotalol, The risk or severity of hyperkalemia can be increased when Sotalol is combined with Nitrofurantoin.]
[L01CD04, cabazitaxel, Cabazitaxel may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03DA01, spironolactone, Nitrofurantoin may increase the hyperkalemic activities of Spironolactone.]
[S02DA03, antipyrine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Antipyrine.]
[A14AA02, stanozolol, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Stanozolol.]
[J01GA01, streptomycin, Nitrofurantoin may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[M03AB01, succinylcholine, The risk or severity of hyperkalemia can be increased when Succinylcholine is combined with Nitrofurantoin.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01CG01, sulbactam, Nitrofurantoin may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, The risk or severity of methemoglobinemia can be increased when Sulfadiazine is combined with Nitrofurantoin.]
[J01EC01, sulfamethoxazole, Nitrofurantoin may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.]
[J01EB04, sulfapyridine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The serum concentration of Nitrofurantoin can be increased when it is combined with Sulfinpyrazone.]
[M01AB02, sulindac, The risk or severity of hyperkalemia can be increased when Sulindac is combined with Nitrofurantoin.]
[M01AX04, apazone, The serum concentration of Nitrofurantoin can be increased when it is combined with Azapropazone.]
[L02BA01, tamoxifen, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Tamoxifen.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[R03CC03, terbutaline, Nitrofurantoin may decrease the excretion rate of Terbutaline which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Nitrofurantoin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Testosterone.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Tetracaine.]
[S03AA02, tetracycline, Nitrofurantoin may decrease the excretion rate of Tetracycline which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Nitrofurantoin may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[G04BE06, moxisylyte, Nitrofurantoin may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Nitrofurantoin may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01ED01, timolol, The risk or severity of hyperkalemia can be increased when Timolol is combined with Nitrofurantoin.]
[P01AB02, tinidazole, Nitrofurantoin may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Nitrofurantoin may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Nitrofurantoin may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[V04CA01, tolbutamide, Nitrofurantoin may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, The risk or severity of hyperkalemia can be increased when Tolmetin is combined with Nitrofurantoin.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Nitrofurantoin may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Nitrofurantoin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A03AA05, trimebutine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Trimebutine.]
[N03AC02, trimethadione, The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Nitrofurantoin.]
[J01EA01, trimethoprim, The risk or severity of hyperkalemia can be increased when Trimethoprim is combined with Nitrofurantoin.]
[C09CA09, azilsartan medoxomil, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Azilsartan medoxomil.]
[R03DX07, roflumilast, Nitrofurantoin may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Nitrofurantoin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[L01EX04, vandetanib, Vandetanib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[R02AA14, oxyquinoline, Nitrofurantoin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[J05AG05, rilpivirine, Rilpivirine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01AA28, vancomycin, Nitrofurantoin may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Nitrofurantoin may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Nitrofurantoin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C08DA01, verapamil, Verapamil may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N06AX09, viloxazine, Nitrofurantoin may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[L01CA01, vinblastine, Vinblastine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01CA02, vincristine, Vincristine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[B01AA03, warfarin, Nitrofurantoin may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[S01AA13, fusidic acid, Fusidic acid may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE02, indinavir, Indinavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01EC01, vemurafenib, Vemurafenib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M05BA05, tiludronic acid, Nitrofurantoin may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Nitrofurantoin may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01MA13, trovafloxacin, The therapeutic efficacy of Trovafloxacin can be decreased when used in combination with Nitrofurantoin.]
[L01XX02, asparaginase, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Asparaginase Escherichia coli.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Nitrofurantoin may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, Nitrofurantoin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, Nitrofurantoin may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, Nitrofurantoin may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, Atenolol may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01FA01, atropine, Atropine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M01CB03, auranofin, Nitrofurantoin may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[L01XJ01, vismodegib, Vismodegib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[B03XA04, peginesatide, Nitrofurantoin may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Nitrofurantoin may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, Nitrofurantoin may decrease the excretion rate of Azathioprine which could result in a higher serum level.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[G04BE10, avanafil, Avanafil may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A08AA11, lorcaserin, Nitrofurantoin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Nitrofurantoin may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[V03AX03, cobicistat, Cobicistat may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L02BB04, enzalutamide, Nitrofurantoin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[L04AA31, teriflunomide, Teriflunomide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01EX05, regorafenib, Regorafenib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[D02BA02, octinoxate, Nitrofurantoin may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, Nelfinavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N04BD02, rasagiline, Nitrofurantoin may decrease the excretion rate of Rasagiline which could result in a higher serum level.]
[C08CA13, lercanidipine, The risk or severity of hyperkalemia can be increased when Lercanidipine is combined with Nitrofurantoin.]
[V09IX04, fluorodeoxyglucose F18, Nitrofurantoin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[V08CA11, gadofosveset, Nitrofurantoin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, Ponatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A16AX08, teduglutide, Nitrofurantoin may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[C04AX11, bencyclane, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Bencyclane.]
[A10BH04, alogliptin, Nitrofurantoin may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Nitrofurantoin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, Nitrofurantoin may decrease the excretion rate of Pomalidomide which could result in a higher serum level.]
[N02BA10, benorilate, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Benorilate.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01MA15, gemifloxacin, The therapeutic efficacy of Gemifloxacin can be decreased when used in combination with Nitrofurantoin.]
[M04AB03, benzbromarone, The serum concentration of Nitrofurantoin can be increased when it is combined with Benzbromarone.]
[S01AE07, moxifloxacin, The therapeutic efficacy of Moxifloxacin can be decreased when used in combination with Nitrofurantoin.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Benzocaine.]
[L03AA12, ancestim, Nitrofurantoin may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, Celecoxib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01EC02, dabrafenib, Dabrafenib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[R02AX03, benzydamine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Benzydamine.]
[L01EE01, trametinib, Nitrofurantoin may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Benzyl alcohol.]
[V09AX05, florbetapir F-18, Nitrofurantoin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[L01EB03, afatinib, Afatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N06AX28, levomilnacipran, Nitrofurantoin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[C08EA02, bepridil, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Bepridil.]
[A10BJ03, lixisenatide, Nitrofurantoin may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[A05AA03, cholic acid, Cholic Acid may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C02KX04, macitentan, Nitrofurantoin may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[N06AX26, vortioxetine, Nitrofurantoin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AP05, simeprevir, Simeprevir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AP08, sofosbuvir, Nitrofurantoin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Nitrofurantoin may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[C07AB04, acebutolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Acebutolol.]
[N05CH03, tasimelteon, Nitrofurantoin may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[L04AA32, apremilast, Nitrofurantoin may decrease the excretion rate of Apremilast which could result in a higher serum level.]
[L02BG02, formestane, Nitrofurantoin may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S01ED02, betaxolol, The risk or severity of hyperkalemia can be increased when Betaxolol is combined with Nitrofurantoin.]
[V03AB34, fomepizole, Nitrofurantoin may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Nitrofurantoin is combined with Acenocoumarol.]
[N07XX08, tafamidis, The serum concentration of Nitrofurantoin can be increased when it is combined with Tafamidis.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S03AA06, gentamicin, Nitrofurantoin may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[J05AP09, dasabuvir, Dasabuvir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Nitrofurantoin is combined with Dicoumarol.]
[B01AF03, edoxaban, Nitrofurantoin may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[L01EF01, palbociclib, Palbociclib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01EX08, lenvatinib, Lenvatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AP07, daclatasvir, Daclatasvir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N02BE01, acetaminophen, The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Nitrofurantoin.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Nitrofurantoin is combined with Tioclomarol.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A04AD14, rolapitant, Rolapitant may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M02AA25, aceclofenac, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Acemetacin.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC03, lansoprazole, Lansoprazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[V03AB37, idarucizumab, Nitrofurantoin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[J02AC05, isavuconazole, Isavuconazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01EB04, osimertinib, Osimertinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Nitrofurantoin.]
[L01XG03, ixazomib, Nitrofurantoin may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[L01ED03, alectinib, Alectinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M04AB05, lesinurad, The serum concentration of Nitrofurantoin can be increased when it is combined with Lesinurad.]
[J05AP10, elbasvir, Elbasvir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AP11, grazoprevir, Grazoprevir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M01AE16, alminoprofen, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Alminoprofen.]
[N03AX23, brivaracetam, Nitrofurantoin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[L01XX52, venetoclax, Venetoclax may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05BA08, bromazepam, Nitrofurantoin may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, Nitrofurantoin may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[C08CA01, amlodipine, The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Nitrofurantoin.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Bupivacaine.]
[C07AA19, bupranolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Bupranolol.]
[N07BC01, buprenorphine, Buprenorphine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01XX27, arsenic trioxide, Nitrofurantoin may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01MA09, sparfloxacin, The therapeutic efficacy of Sparfloxacin can be decreased when used in combination with Nitrofurantoin.]
[L01XK03, rucaparib, Rucaparib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A07EC04, balsalazide, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Balsalazide.]
[A06AH05, naldemedine, Nitrofurantoin may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Nitrofurantoin may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N06BC01, caffeine, Caffeine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C09AA07, benazepril, The risk or severity of hyperkalemia can be increased when Benazepril is combined with Nitrofurantoin.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Oxybuprocaine.]
[P01CA02, benznidazole, Nitrofurantoin may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J05AF06, abacavir, Nitrofurantoin may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[J05AE09, tipranavir, Tipranavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N07XX13, valbenazine, Nitrofurantoin may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L01ED04, brigatinib, Brigatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N04BD03, safinamide, Safinamide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01MA23, delafloxacin, The therapeutic efficacy of Delafloxacin can be decreased when used in combination with Nitrofurantoin.]
[L01BC06, capecitabine, Nitrofurantoin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XX59, enasidenib, Enasidenib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01EF03, abemaciclib, Abemaciclib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C07AB07, bisoprolol, The risk or severity of hyperkalemia can be increased when Bisoprolol is combined with Nitrofurantoin.]
[J05AG03, efavirenz, Efavirenz may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C07AA17, bopindolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Bopindolol.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Nitrofurantoin may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[M01AB07, bumadizone, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Bumadizone.]
[J05AX18, letermovir, Letermovir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Capsaicin.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Nitrofurantoin may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Captopril.]
[L02BB05, apalutamide, Apalutamide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AF01, carbamazepine, Nitrofurantoin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C07AG02, carvedilol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Carvedilol.]
[B02BX09, fostamatinib, Fostamatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N03AX24, cannabidiol, Cannabidiol may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[B02BX08, avatrombopag, Avatrombopag may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L04AA37, baricitinib, Nitrofurantoin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01GB14, plazomicin, Nitrofurantoin may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Celiprolol.]
[A16AX14, migalastat, Nitrofurantoin may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The excretion of Nitrofurantoin can be decreased when combined with Stiripentol.]
[L01EB07, dacomitinib, Dacomitinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Chloroprocaine.]
[D08AE05, chloroxylenol, Nitrofurantoin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Lornoxicam.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01EX13, gilteritinib, Gilteritinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01XJ03, glasdegib, Glasdegib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A06AX05, prucalopride, Nitrofurantoin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C09AA08, cilazapril, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Cilazapril.]
[B01AC23, cilostazol, Nitrofurantoin may decrease the excretion rate of Cilostazol which could result in a higher serum level.]
[J01FA09, clarithromycin, Nitrofurantoin may decrease the excretion rate of Clarithromycin which could result in a higher serum level.]
[N06BA14, solriamfetol, Nitrofurantoin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[N05BA09, clobazam, Clobazam may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C09CA06, candesartan, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Candesartan.]
[J01DC04, cefaclor, Nitrofurantoin may decrease the excretion rate of Cefaclor which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L02BB06, darolutamide, The serum concentration of Nitrofurantoin can be increased when it is combined with Darolutamide.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01EJ02, fedratinib, Fedratinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N07XX11, pitolisant, Nitrofurantoin may decrease the excretion rate of Pitolisant which could result in a higher serum level.]
[N04CX01, istradefylline, Istradefylline may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N02CC08, lasmiditan, The serum concentration of Nitrofurantoin can be increased when it is combined with Lasmiditan.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M09AX08, golodirsen, Nitrofurantoin may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Nitrofurantoin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[S01AE06, gatifloxacin, The therapeutic efficacy of Gatifloxacin can be decreased when used in combination with Nitrofurantoin.]
[R02AA03, dichlorobenzyl alcohol, Nitrofurantoin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Nitrofurantoin may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[M01AH02, rofecoxib, The risk or severity of hyperkalemia can be increased when Rofecoxib is combined with Nitrofurantoin.]
[C08CA16, clevidipine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Clevidipine.]
[L01EX17, capmatinib, The serum concentration of Nitrofurantoin can be increased when it is combined with Capmatinib.]
[M01AC04, droxicam, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Droxicam.]
[L01EX19, ripretinib, Ripretinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[V08CA05, mangafodipir, Nitrofurantoin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[M02AA27, dexketoprofen, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Dexketoprofen.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Dyclonine.]
[J05AX29, fostemsavir, Fostemsavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01FX15, belantamab mafodotin, Nitrofurantoin may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.]
[P01BA01, chloroquine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Nitrofurantoin.]
[L01EX23, pralsetinib, Pralsetinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AA01, chlorpromazine, Chlorpromazine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N02BA07, ethenzamide, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Ethenzamide.]
[N02BA03, choline salicylate, Nitrofurantoin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[N06BX18, vinpocetine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Vinpocetine.]
[M01AB08, etodolac, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Etofenamate.]
[M01AX25, chondroitin sulfates, Nitrofurantoin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[L01EX21, tepotinib, Tepotinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M01AE05, fenbufen, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Fenbufen.]
[C01CA19, fenoldopam, Nitrofurantoin may decrease the excretion rate of Fenoldopam which could result in a higher serum level.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01MB07, flumequine, The therapeutic efficacy of Flumequine can be decreased when used in combination with Nitrofurantoin.]
[S02BA08, fluocinolone acetonide, Fluocinolone acetonide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01JA01, fluorescein, Fluorescein may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N02BG07, flupirtine, Nitrofurantoin may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[L01EK03, tivozanib, Tivozanib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A02BA01, cimetidine, Cimetidine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N07CA02, cinnarizine, The risk or severity of hyperkalemia can be increased when Cinnarizine is combined with Nitrofurantoin.]
[J01MB06, cinoxacin, The therapeutic efficacy of Cinoxacin can be decreased when used in combination with Nitrofurantoin.]
[L01XX73, sotorasib, The serum concentration of Nitrofurantoin can be increased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The therapeutic efficacy of Ciprofloxacin can be decreased when used in combination with Nitrofurantoin.]
[L01XA01, cisplatin, Nitrofurantoin may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA48, belumosudil, Belumosudil may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[V09AB03, ioflupane I-123, Nitrofurantoin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Nitrofurantoin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Nitrofurantoin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[M01AG01, mefenamic acid, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Mefenamic acid.]
[A10BB12, glimepiride, Glimepiride may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AX10, maribavir, Maribavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J04BA01, clofazimine, Clofazimine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C10AB01, clofibrate, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Clofibrate.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Nitrofurantoin can be increased when it is combined with Pacritinib.]
[N06AA04, clomipramine, Nitrofurantoin may decrease the excretion rate of Clomipramine which could result in a higher serum level.]
[N03AE01, clonazepam, Nitrofurantoin may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J02AC06, oteseconazole, The serum concentration of Nitrofurantoin can be increased when it is combined with Oteseconazole.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[A05BA08, glycyrrhizic acid, Nitrofurantoin may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.]
[N05AH02, clozapine, Clozapine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A10BK06, sotagliflozin, Sotagliflozin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01GB12, arbekacin, Nitrofurantoin may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Cocaine.]
[M01AX13, proquazone, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Proquazone.]
[M04AC01, colchicine, Nitrofurantoin may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Nitrofurantoin may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A04AA03, tropisetron, Nitrofurantoin may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, Nitrofurantoin may decrease the excretion rate of Nateglinide which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Imidazole salicylate.]
[R03BA08, ciclesonide, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Ciclesonide.]
[B01AC10, indobufen, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Indobufen.]
[J05AB14, valganciclovir, Nitrofurantoin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Nitrofurantoin may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Nitrofurantoin may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Nitrofurantoin may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Nitrofurantoin may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Nitrofurantoin may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The risk or severity of hyperkalemia can be increased when Valdecoxib is combined with Nitrofurantoin.]
[A03AX10, isometheptene, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Isometheptene.]
[N02CC05, almotriptan, Nitrofurantoin may decrease the excretion rate of Almotriptan which could result in a higher serum level.]
[M01AH04, parecoxib, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Parecoxib.]
[J02AC02, itraconazole, Itraconazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[B01AB12, bemiparin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Bemiparin.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05BA10, ketazolam, Nitrofurantoin may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Kebuzone.]
[L01EA01, imatinib, Imatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C08CA09, lacidipine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Lacidipine.]
[V03AF07, rasburicase, The risk or severity of methemoglobinemia can be increased when Rasburicase is combined with Nitrofurantoin.]
[N03AX09, lamotrigine, The risk or severity of hyperkalemia can be increased when Lamotrigine is combined with Nitrofurantoin.]
[N07BC04, lofexidine, Nitrofurantoin may decrease the excretion rate of Lofexidine which could result in a higher serum level.]
[S01AE04, lomefloxacin, The therapeutic efficacy of Lomefloxacin can be decreased when used in combination with Nitrofurantoin.]
[M01AB09, lonazolac, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Lonazolac.]
[R06AX13, loratadine, Loratadine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M02AA31, loxoprofen, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Loxoprofen.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C09AA03, lisinopril, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Lisinopril.]
[A06AD01, magnesium carbonate, Nitrofurantoin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Manidipine.]
[C07AA14, mepindolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Mepindolol.]
[H02AB15, meprednisone, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Meprednisone.]
[J01DH02, meropenem, Nitrofurantoin may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[C04AX01, cyclandelate, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Cyclandelate.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Nitrofurantoin may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01AA01, cyclophosphamide, The risk or severity of methemoglobinemia can be increased when Cyclophosphamide is combined with Nitrofurantoin.]
[S01XA18, cyclosporine, Cyclosporine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C09AA13, moexipril, The risk or severity of hyperkalemia can be increased when Moexipril is combined with Nitrofurantoin.]
[C10AA07, rosuvastatin, Nitrofurantoin may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[M02AA02, mofebutazone, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Morniflumate.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AH05, etoricoxib, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Etoricoxib.]
[L01AX04, dacarbazine, Nitrofurantoin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[G03XA01, danazol, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Danazol.]
[M03CA01, dantrolene, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Dantrolene.]
[J04BA02, dapsone, The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Nitrofurantoin.]
[L01DB02, daunorubicin, Daunorubicin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M01AX01, nabumetone, The risk or severity of hyperkalemia can be increased when Nabumetone is combined with Nitrofurantoin.]
[N07BB05, nalmefene, Nitrofurantoin may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[B05XA15, potassium lactate, Potassium lactate may increase the hyperkalemic activities of Nitrofurantoin.]
[C07AB12, nebivolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Nebivolol.]
[S01GX04, nedocromil, Nitrofurantoin may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, Nitrofurantoin may decrease the excretion rate of Nefazodone which could result in a higher serum level.]
[C01DX16, nicorandil, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Nicorandil.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M03AC11, cisatracurium, Nitrofurantoin may increase the neuromuscular blocking activities of Cisatracurium.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A07EC03, olsalazine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Olsalazine.]
[N06AA01, desipramine, Nitrofurantoin may decrease the excretion rate of Desipramine which could result in a higher serum level.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[V04CH02, indigo carmine, Nitrofurantoin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C09XA02, aliskiren, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Aliskiren.]
[M01AE12, oxaprozin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Oxaprozin.]
[S03BA01, dexamethasone, Dexamethasone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01EB01, gefitinib, Gefitinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N07BC06, heroin, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Diamorphine.]
[P03AC04, permethrin, Nitrofurantoin may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Nitrofurantoin may decrease the excretion rate of Diazepam which could result in a higher serum level.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Cinchocaine.]
[R05DA08, pholcodine, Nitrofurantoin may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Diclofenac may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A03AA07, dicyclomine, Nitrofurantoin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF02, didanosine, Nitrofurantoin may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[A03AX04, pinaverium, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Pinaverium.]
[L01EB02, erlotinib, Erlotinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[L02AA01, diethylstilbestrol, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Diethylstilbestrol.]
[C08CA03, isradipine, Isradipine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[D07XC04, diflucortolone, Nitrofurantoin may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Diflunisal.]
[C01AA05, digoxin, Nitrofurantoin may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C10AX09, ezetimibe, Nitrofurantoin may decrease the excretion rate of Ezetimibe which could result in a higher serum level.]
[L01XX24, pegaspargase, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Pegaspargase.]
[C04AE04, dihydroergocristine, Nitrofurantoin may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AE08, atazanavir, Nitrofurantoin may decrease the excretion rate of Atazanavir which could result in a higher serum level.]
[H03BC01, potassium perchlorate, Potassium perchlorate may increase the hyperkalemic activities of Nitrofurantoin.]
[V03AB04, pralidoxime, Nitrofurantoin may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Pramocaine.]
[C08DB01, diltiazem, The risk or severity of hyperkalemia can be increased when Diltiazem is combined with Nitrofurantoin.]
[V03AB09, dimercaprol, Nitrofurantoin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, Nitrofurantoin may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N02BB04, propyphenazone, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Proglumetacin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Diphenhydramine.]
[C09AA06, quinapril, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Quinapril.]
[B01AC07, dipyridamole, Nitrofurantoin may decrease the excretion rate of Dipyridamole which could result in a higher serum level.]
[C09AA05, ramipril, The risk or severity of hyperkalemia can be increased when Ramipril is combined with Nitrofurantoin.]
[S01AX06, resorcinol, Nitrofurantoin may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Disopyramide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[P03AA04, disulfiram, Nitrofurantoin may decrease the excretion rate of Disulfiram which could result in a higher serum level.]
[R06AE09, levocetirizine, Nitrofurantoin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Ropivacaine.]
[J01MB01, rosoxacin, The therapeutic efficacy of Rosoxacin can be decreased when used in combination with Nitrofurantoin.]
[L01EX01, sunitinib, Sunitinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE08, tadalafil, Nitrofurantoin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01BC05, ketorolac, The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Nitrofurantoin.]
[C01EB18, ranolazine, Ranolazine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N02BA06, salsalate, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Salsalate.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C01CA07, dobutamine, Nitrofurantoin may decrease the excretion rate of Dobutamine which could result in a higher serum level.]
[C01CA04, dopamine, Nitrofurantoin may decrease the excretion rate of Dopamine which could result in a higher serum level.]
[N06AA12, doxepin, Nitrofurantoin may decrease the excretion rate of Doxepin which could result in a higher serum level.]
[L01DB01, doxorubicin, Nitrofurantoin may decrease the excretion rate of Doxorubicin which could result in a higher serum level.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A08AA10, sibutramine, Nitrofurantoin may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[C10AA01, simvastatin, Simvastatin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[V03AG05, sodium phosphate, Sodium phosphate, monobasic may increase the hyperkalemic activities of Nitrofurantoin.]
[A12CA02, sodium sulfate, Nitrofurantoin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[C09AA11, spirapril, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Spirapril.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[V04CX07, edrophonium, Nitrofurantoin may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[C07AB13, talinolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Talinolol.]
[J01MA05, temafloxacin, The therapeutic efficacy of Temafloxacin can be decreased when used in combination with Nitrofurantoin.]
[L01AX03, temozolomide, Nitrofurantoin may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, The risk or severity of hyperkalemia can be increased when Tenoxicam is combined with Nitrofurantoin.]
[G04BD05, terodiline, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Terodiline.]
[C07AA16, tertatolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Tertatolol.]
[C09AA02, enalapril, The risk or severity of hyperkalemia can be increased when Enalapril is combined with Nitrofurantoin.]
[M01AG02, tolfenamic acid, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Tolfenamic acid.]
[N06AG03, toloxatone, Nitrofurantoin may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA10, trandolapril, The risk or severity of hyperkalemia can be increased when Trandolapril is combined with Nitrofurantoin.]
[N05CC01, chloral hydrate, Nitrofurantoin may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[J01MA04, enoxacin, The therapeutic efficacy of Enoxacin can be decreased when used in combination with Nitrofurantoin.]
[N06AX16, venlafaxine, Venlafaxine may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA12, mepirodipine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Barnidipine.]
[C09AA15, zofenopril, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Zofenopril.]
[M01AB04, zomepirac, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Zomepirac.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF01, zopiclone, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Zopiclone.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C02AC02, guanfacine, Nitrofurantoin may decrease the excretion rate of Guanfacine which could result in a higher serum level.]
[N03AG01, valproic acid, The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Nitrofurantoin.]
[L03AX05, pidotimod, Nitrofurantoin may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, Erythromycin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CD04, estazolam, Nitrofurantoin may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[G03CA03, estradiol, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Estradiol.]
[G03CC06, estriol, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Estriol.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Conjugated estrogens.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[R03BA09, fluticasone furoate, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Fluticasone furoate.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L02AA03, ethinyl estradiol, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Ethinylestradiol.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N03AD01, ethosuximide, The risk or severity of hyperkalemia can be increased when Ethosuximide is combined with Nitrofurantoin.]
[N03AB01, ethotoin, The therapeutic efficacy of Ethotoin can be increased when used in combination with Nitrofurantoin.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Etidocaine.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L04AD02, tacrolimus, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Tacrolimus.]
[J01MA08, fleroxacin, The therapeutic efficacy of Fleroxacin can be decreased when used in combination with Nitrofurantoin.]
[R06AX11, astemizole, Astemizole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[R06AX12, terfenadine, Terfenadine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[P01AX07, trimetrexate, Nitrofurantoin may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Nitrofurantoin may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[N06AB08, fluvoxamine, Fluvoxamine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C10AA03, pravastatin, Pravastatin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Nitrofurantoin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[D11AX24, deoxycholic acid, Deoxycholic acid may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[B05AA05, dextran, Nitrofurantoin may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C08CA02, felodipine, Nitrofurantoin may decrease the excretion rate of Felodipine which could result in a higher serum level.]
[C08EA01, fendiline, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Fendiline.]
[M01AE04, fenoprofen, The risk or severity of hyperkalemia can be increased when Fenoprofen is combined with Nitrofurantoin.]
[N02AB03, fentanyl, Nitrofurantoin may decrease the excretion rate of Fentanyl which could result in a higher serum level.]
[R03CC02, albuterol, Nitrofurantoin may decrease the excretion rate of Salbutamol which could result in a higher serum level.]
[L01BB06, clofarabine, Clofarabine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[G04BD02, flavoxate, Nitrofurantoin may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[N02BG04, floctafenine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Floctafenine.]
[J01CF05, floxacillin, Flucloxacillin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J02AC01, fluconazole, The risk or severity of adverse effects can be increased when Nitrofurantoin is combined with Fluconazole.]
[J02AX01, flucytosine, Nitrofurantoin may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Nitrofurantoin may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[N07CA03, flunarizine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Flunarizine.]
[D07AC08, fluocinonide, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Fluocinonide.]
[L01BC09, floxuridine, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Floxuridine.]
[L01BC02, fluorouracil, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Fluorouracil.]
[N05CD01, flurazepam, Flurazepam may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01BC04, flurbiprofen, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Flurbiprofen.]
[N05AG01, fluspirilene, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Fluspirilene.]
[L02BB01, flutamide, The risk or severity of methemoglobinemia can be increased when Flutamide is combined with Nitrofurantoin.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S02AA17, fosfomycin, Nitrofurantoin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01BC03, tegafur, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Tegafur.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C08DA02, gallopamil, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Gallopamil.]
[S01AD09, ganciclovir, Nitrofurantoin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C10AB04, gemfibrozil, Nitrofurantoin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.]
[J01XA03, telavancin, Nitrofurantoin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, Dasatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N03AD03, methsuximide, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Methsuximide.]
[A10BB01, glyburide, Glyburide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A10BB07, glipizide, Nitrofurantoin may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C05AE01, nitroglycerin, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Nitroglycerin.]
[L01EX02, sorafenib, Sorafenib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C07AB09, esmolol, The risk or severity of hyperkalemia can be increased when Esmolol is combined with Nitrofurantoin.]
[M01CB04, aurothioglucose, Nitrofurantoin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Nitrofurantoin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Nitrofurantoin is combined with Fluindione.]
[C09AA09, fosinopril, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Nitrofurantoin.]
[S01EX01, guanethidine, Nitrofurantoin may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05AD01, haloperidol, Haloperidol may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05AH04, quetiapine, Nitrofurantoin may decrease the excretion rate of Quetiapine which could result in a higher serum level.]
[N06BX13, idebenone, Nitrofurantoin may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[M04AA01, allopurinol, The serum concentration of Nitrofurantoin can be increased when it is combined with Allopurinol.]
[C09CA01, losartan, Losartan may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01XA14, heparin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Heparin.]
[G03DC01, allylestrenol, Nitrofurantoin may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Nitrofurantoin.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C08CA10, nilvadipine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Nimesulide.]
[C09AA04, perindopril, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Perindopril.]
[C02DB02, hydralazine, Nitrofurantoin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Potassium acetate may increase the hyperkalemic activities of Nitrofurantoin.]
[S01XA07, aluminum potassium sulfate, Potassium alum may increase the hyperkalemic activities of Nitrofurantoin.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[G04BD06, propiverine, Nitrofurantoin may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[B05AA07, hetastarch, Nitrofurantoin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[L01XX05, hydroxyurea, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Hydroxyurea.]
[R02AX02, ibuprofen, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Ibuprofen.]
[B05XA08, sodium acetate, Nitrofurantoin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01AA06, ifosfamide, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Ifosfamide.]
[N06AA02, imipramine, Imipramine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01CD01, paclitaxel, Paclitaxel may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[R01AD07, tixocortol, Nitrofurantoin may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[L01CE01, topotecan, Nitrofurantoin may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, Indomethacin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A11HA07, inositol, Nitrofurantoin may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, Nitrofurantoin may decrease the excretion rate of Milnacipran which could result in a higher serum level.]
[S01XA28, varenicline, Nitrofurantoin may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Articaine.]
[A10BH01, sitagliptin, Nitrofurantoin may decrease the excretion rate of Sitagliptin which could result in a higher serum level.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CH02, ramelteon, Nitrofurantoin may decrease the excretion rate of Ramelteon which could result in a higher serum level.]
[C10AA06, cerivastatin, Cerivastatin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C07AA01, alprenolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Alprenolol.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, Nitrofurantoin may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[C09AA16, imidapril, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Imidapril.]
[J04AC01, isoniazid, Nitrofurantoin may decrease the excretion rate of Isoniazid which could result in a higher serum level.]
[J05AX05, inosine pranobex, Nitrofurantoin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Isosorbide mononitrate.]
[C05AE02, isosorbide dinitrate, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Isosorbide dinitrate.]
[D10BA01, isotretinoin, Nitrofurantoin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[S01AA24, kanamycin, Nitrofurantoin may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[N01AX03, ketamine, Nitrofurantoin may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[B01AC22, prasugrel, Nitrofurantoin may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[J02AB02, ketoconazole, Ketoconazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M02AA10, ketoprofen, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Ketoprofen.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01MB02, nalidixic acid, The therapeutic efficacy of Nalidixic acid can be decreased when used in combination with Nitrofurantoin.]
[M01AE11, tiaprofenic acid, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Tiaprofenic acid.]
[C07AG01, labetalol, The risk or severity of hyperkalemia can be increased when Labetalol is combined with Nitrofurantoin.]
[N04BB01, amantadine, Nitrofurantoin may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Nitrofurantoin.]
[A06AX03, lubiprostone, Nitrofurantoin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[A05AA02, ursodiol, Ursodeoxycholic acid may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Lidocaine.]
[C08EX01, lidoflazine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Lidoflazine.]
[S01AA21, amikacin, Nitrofurantoin may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[A07DA03, loperamide, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Loperamide.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C10AA02, lovastatin, Lovastatin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[B05XA11, magnesium chloride, Nitrofurantoin may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Nitrofurantoin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[V04CC02, magnesium sulfate, The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Nitrofurantoin.]
[L01BA05, pralatrexate, Nitrofurantoin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, Nilotinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Nitrofurantoin may decrease the excretion rate of Maprotiline which could result in a higher serum level.]
[C02BB01, mecamylamine, Mecamylamine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M02AA18, meclofenamic acid, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Meclofenamic acid.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB06, nadroparin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Nadroparin.]
[B01AB05, enoxaparin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Enoxaparin.]
[B01AB04, dalteparin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Dalteparin.]
[N06DX01, memantine, Nitrofurantoin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N03AB04, mephenytoin, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Mephenytoin.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Mepivacaine.]
[G04BX16, tiopronin, Nitrofurantoin may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Nitrofurantoin may decrease the excretion rate of Paliperidone which could result in a higher serum level.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N07BC02, methadone, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Methadone.]
[N06BA03, methamphetamine, Nitrofurantoin may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[J05AF05, lamivudine, Nitrofurantoin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, Nitrofurantoin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01BA04, pemetrexed, Nitrofurantoin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L04AX03, methotrexate, Methotrexate may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, Nitrofurantoin may decrease the excretion rate of Methyldopa which could result in a higher serum level.]
[V04CG05, methylene blue, Nitrofurantoin may decrease the excretion rate of Methylene blue which could result in a higher serum level.]
[G03EK01, methyltestosterone, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Methyltestosterone.]
[A03FA01, metoclopramide, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Metoclopramide.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, The risk or severity of hyperkalemia can be increased when Metoprolol is combined with Nitrofurantoin.]
[V04CD01, metyrapone, Nitrofurantoin may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[N02BB03, aminopyrine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Aminophenazone.]
[B01AB07, parnaparin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Parnaparin.]
[N05CD08, midazolam, Midazolam may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[G03XB01, mifepristone, Nitrofurantoin may decrease the excretion rate of Mifepristone which could result in a higher serum level.]
[B01AB10, tinzaparin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Tinzaparin.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C09CA03, valsartan, The risk or severity of hyperkalemia can be increased when Valsartan is combined with Nitrofurantoin.]
[L01XX23, mitotane, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Mitotane.]
[L03AC01, aldesleukin, Aldesleukin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C01BD01, amiodarone, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Amiodarone.]
[N06AA09, amitriptyline, Amitriptyline may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L04AB05, certolizumab pegol, Nitrofurantoin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[B02BX05, eltrombopag, Eltrombopag may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[G04BA01, ammonium chloride, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Ammonium chloride.]
[L04AA06, mycophenolic acid, Nitrofurantoin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[N03AB05, fosphenytoin, The therapeutic efficacy of Fosphenytoin can be increased when used in combination with Nitrofurantoin.]
[C07AA12, nadolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Nadolol.]
[J01CA04, amoxicillin, Nitrofurantoin may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[V03AB15, naloxone, Nitrofurantoin may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[S01XA11, nandrolone, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Nandrolone phenpropionate.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M02AA12, naproxen, Nitrofurantoin may decrease the excretion rate of Naproxen which could result in a higher serum level.]
[A10BG01, troglitazone, Troglitazone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N06AX21, duloxetine, Duloxetine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S03AA01, neomycin, Nitrofurantoin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A10BX02, repaglinide, Nitrofurantoin may decrease the excretion rate of Repaglinide which could result in a higher serum level.]
[B01AC17, tirofiban, Nitrofurantoin may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L03AX16, plerixafor, Nitrofurantoin may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Nitrofurantoin may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Nitrofurantoin may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M04AA03, febuxostat, The excretion of Nitrofurantoin can be decreased when combined with Febuxostat.]
[C01CE01, inamrinone, Nitrofurantoin may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[C10AD02, niacin, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Niacin.]
[C08CA04, nicardipine, Nicardipine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C08CA05, nifedipine, Nitrofurantoin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M02AA17, niflumic acid, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Niflumic acid.]
[V03AB22, amyl nitrite, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Amyl Nitrite.]
[C08CA06, nimodipine, The risk or severity of hyperkalemia can be increased when Nimodipine is combined with Nitrofurantoin.]
[C08CA07, nisoldipine, The risk or severity of hyperkalemia can be increased when Nisoldipine is combined with Nitrofurantoin.]
[C08CA08, nitrendipine, Nitrofurantoin may decrease the excretion rate of Nitrendipine which could result in a higher serum level.]
[R07AX01, nitric oxide, The risk or severity of methemoglobinemia can be increased when Nitric Oxide is combined with Nitrofurantoin.]
[J01MB04, pipemidic acid, The therapeutic efficacy of Pipemidic acid can be decreased when used in combination with Nitrofurantoin.]
[C01DA05, pentaerythritol tetranitrate, Nitrofurantoin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[N05CF03, zaleplon, Nitrofurantoin may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C02DD01, nitroprusside, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Nitrofurantoin.]
[N01AX13, nitrous oxide, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Nitrous oxide.]
[S01AE02, norfloxacin, The therapeutic efficacy of Norfloxacin can be decreased when used in combination with Nitrofurantoin.]
[C02KX01, bosentan, Bosentan may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[G02CA02, nylidrin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Nylidrin.]
[B01AB08, reviparin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Reviparin.]
[S02AA16, ofloxacin, The therapeutic efficacy of Ofloxacin can be decreased when used in combination with Nitrofurantoin.]
[A02BC01, omeprazole, Omeprazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N02AA02, opium, Nitrofurantoin may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04CA02, tamsulosin, Nitrofurantoin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01CF04, oxacillin, Nitrofurantoin may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[A14AA08, oxandrolone, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Oxandrolone.]
[N05BA04, oxazepam, Nitrofurantoin may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[J01MB05, oxolinic acid, The therapeutic efficacy of Oxolinic acid can be decreased when used in combination with Nitrofurantoin.]
[C07AA02, oxprenolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Oxprenolol.]
[A14AA05, oxymetholone, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Oxymetholone.]
[S01BC02, oxyphenbutazone, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Oxyphenbutazone.]
[J04AA01, aminosalicylic acid, The risk or severity of methemoglobinemia can be increased when Aminosalicylic acid is combined with Nitrofurantoin.]
[B01AB09, danaparoid, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Danaparoid.]
[J04AB30, capreomycin, Nitrofurantoin may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01MA03, pefloxacin, The therapeutic efficacy of Pefloxacin can be decreased when used in combination with Nitrofurantoin.]
[G04BD11, fesoterodine, Nitrofurantoin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Penbutolol.]
[N05AG03, penfluridol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Penfluridol.]
[J01CE09, penicillin G procaine, Nitrofurantoin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, Pentobarbital may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[L01XX08, pentostatin, Nitrofurantoin may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Nitrofurantoin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C08EX02, perhexiline, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Perhexiline.]
[G04BX06, phenazopyridine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Phenazopyridine.]
[N06AF03, phenelzine, Nitrofurantoin may decrease the excretion rate of Phenelzine which could result in a higher serum level.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Nitrofurantoin is combined with Phenindione.]
[N03AA02, phenobarbital, Phenobarbital may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Nitrofurantoin is combined with Phenprocoumon.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[M02AA01, phenylbutazone, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Phenylbutazone.]
[N03AB02, phenytoin, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Nitrofurantoin.]
[S01AE05, levofloxacin, The therapeutic efficacy of Levofloxacin can be decreased when used in combination with Nitrofurantoin.]
[B02BA01, vitamin K1, Nitrofurantoin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C08CX01, mibefradil, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Mibefradil.]
[C07AA03, pindolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Pindolol.]
[C10AA05, atorvastatin, Nitrofurantoin may decrease the excretion rate of Atorvastatin which could result in a higher serum level.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AE01, saquinavir, Saquinavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N06BX03, piracetam, Nitrofurantoin may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Eprosartan.]
[S01BC06, piroxicam, The risk or severity of hyperkalemia can be increased when Piroxicam is combined with Nitrofurantoin.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01MA11, grepafloxacin, The therapeutic efficacy of Grepafloxacin can be decreased when used in combination with Nitrofurantoin.]
[C09CA04, irbesartan, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Irbesartan.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, Ritonavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A10BH03, saxagliptin, Nitrofurantoin may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Potassium chloride may increase the hyperkalemic activities of Nitrofurantoin.]
[V03AB21, potassium iodide, Potassium Iodide may increase the hyperkalemic activities of Nitrofurantoin.]
[C10AA08, pitavastatin, Nitrofurantoin may decrease the excretion rate of Pitavastatin which could result in a higher serum level.]
[C07AB01, practolol, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Practolol.]
[H02AB07, prednisone, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Prednisone.]
[C01DX02, prenylamine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Prenylamine.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Prilocaine.]
[P01BA03, primaquine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Primaquine.]
[M04AB01, probenecid, The serum concentration of Nitrofurantoin can be increased when it is combined with Probenecid.]
[C01BA02, procainamide, Nitrofurantoin may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Procaine.]
[C10AB05, fenofibrate, Nitrofurantoin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[G03DA04, progesterone, Progesterone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[R06AD02, promethazine, Nitrofurantoin may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[C01BC03, propafenone, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Propafenone.]
[A03AB05, propantheline, Nitrofurantoin may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[C07AA05, propranolol, The risk or severity of hyperkalemia can be increased when Propranolol is combined with Nitrofurantoin.]
[N02CC04, rizatriptan, Nitrofurantoin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[B01AC09, epoprostenol, Nitrofurantoin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.]
[N07XX07, dalfampridine, Nitrofurantoin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Nitrofurantoin may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[A12BA05, potassium gluconate, Potassium gluconate may increase the hyperkalemic activities of Nitrofurantoin.]
[C01BA01, quinidine, Nitrofurantoin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, The risk or severity of methemoglobinemia can be increased when Quinine is combined with Nitrofurantoin.]
[A02BA02, ranitidine, Nitrofurantoin may decrease the excretion rate of Ranitidine which could result in a higher serum level.]
[C02AA01, rescinnamine, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Rescinnamine.]
[C02AA02, reserpine, Reserpine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J05AP01, ribavirin, Nitrofurantoin may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[J04AB02, rifampin, Rifampicin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N02BA05, salicylamide, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Salicylamide.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[S01BC08, salicylic acid, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Salicylic acid.]
[N05CA06, secobarbital, Secobarbital may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[J01GB08, sisomicin, Nitrofurantoin may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Nitrofurantoin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Nitrofurantoin may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C07AA07, sotalol, The risk or severity of hyperkalemia can be increased when Sotalol is combined with Nitrofurantoin.]
[L01CD04, cabazitaxel, Cabazitaxel may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C03DA01, spironolactone, Nitrofurantoin may increase the hyperkalemic activities of Spironolactone.]
